What is Veracyte's financing cash flow?

Veracyte (VCYT) reported financing cash flow of -$6.63M in Q1 2026.

How has Veracyte's financing cash flow changed year-over-year?

Veracyte's financing cash flow decreased by 2.2% year-over-year, from -$6.48M to -$6.63M.

What is the long-term trend for Veracyte's financing cash flow?

Over 2 years (2021 to 2023), Veracyte's financing cash flow has grown at a -93.1% compound annual growth rate (CAGR), from $596.32M to $2.84M.

What does financing cash flow mean?

Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.

Veracyte VCYT Financing Cash Flow

Financing Cash Flow at other companies

Guardant HealthGH

-$21.58M+67.7%

Natera, Inc.NTRA

$3.76M+591%

Bio-Rad LaboratoriesBIO

-$44M+55.0%

RevvityRVTY

-$88.9M+45.7%

Labcorp HoldingsLH

$580.5M+169%

Quest DiagnosticsDGX

-$152M+72.9%

Other financials

Income statement

See full

Revenue$139.1M+21.5%

Gross profit$101.2M+27.2%

Operating income$22.6M+680%

Net income$28.7M+307%

EPS (diluted)$0.35+289%

Balance sheet

See full

Cash & equivalents$264.8M+41.0%

Total debt$39.3M-22.1%

Total equity$1.3B+12.5%

Total assets$1.4B+9.2%

Cash flow

See full

Operating cash flow$35.2M+557%

CapEx$3.0M+62.8%

Free cash flow$32.3M+810%

Valuation

See full

Market cap$4.29B+10.7%

Profitability

See full

Gross margin70.9%+2.9pp

Operating margin14.3%+9.2pp

Net margin16.2%+9.1pp

FCF margin28.7%+11.7pp

Returns & leverage

See full

Return on equity6.9%+4.1pp

Debt / equity0×0.0×

Current ratio9.3×+4.2×

Where this comes from

Reported directly by Veracyte in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The official record: Veracyte’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Veracyte's financing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Veracyte's financing cash flow?: Veracyte (VCYT) reported financing cash flow of -$6.63M in Q1 2026.
How has Veracyte's financing cash flow changed year-over-year?: Veracyte's financing cash flow decreased by 2.2% year-over-year, from -$6.48M to -$6.63M.
What is the long-term trend for Veracyte's financing cash flow?: Over 2 years (2021 to 2023), Veracyte's financing cash flow has grown at a -93.1% compound annual growth rate (CAGR), from $596.32M to $2.84M.
What does financing cash flow mean?: Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.